iOS app Android app


Cost of Medicines

Manoj Jain, MD MPH | Posted 01.06.2017 | Healthy Living
Manoj Jain, MD MPH

Unless the public is outraged and raises a voice with Congress, the pharmaceutical companies will continue to reap a profit at the cost of patients' pain -- both physical and financial.

Escalating Drug Prices Likely from Secret "Fast Track" Trade Bill

Ellen R. Shaffer | Posted 06.10.2016 | Politics
Ellen R. Shaffer

Congress could vote this week on a "Fast-Track" trade bill that would dump a double whammy on the many Americans whose health and finances are already hit hard by the high price of prescription drugs.

Our Lives Are Worth It

Bob Tufts | Posted 10.18.2014 | Impact
Bob Tufts

Far from "driving up overall health care costs," my at-home treatment keeps me out of the hospital where I would risk infection, lose time and be a far more expensive burden on the health care system. Our lives ARE worth it -- to us, our families and friends, to the health care system and to society at large.

I'd Rather Stay Sick, Thanks

Susan Silver | Posted 03.29.2013 | Comedy
Susan Silver

I noticed something that I'd sort of subliminally registered before but now it was made abundantly clear. Advertising of medicines are plenty scary!

Honesty and Intimacy Are Not Always the Same

Vivian Diller, Ph.D. | Posted 09.01.2012 | Women
Vivian Diller, Ph.D.

A successful long-term relationship means being willing to share your vulnerabilities and strengths, but requires sensitivity to the consequences that sharing brings.

Attention Deficit Déjà Vu

Mike Doyle | Posted 05.25.2011 | Chicago
Mike Doyle

ADDers often feel like we're living in a separate world, without the vocabulary to explain to outsiders the all-encompassing nature and tenacity of the disorder we fight on a minute-by-minute basis.

Biologics: The Case for 13 or More Years of Data Exclusivity

Pat Choate | Posted 05.25.2011 | Technology
Pat Choate

The United States will only realize this potential and remain the global leader in medical innovation if we maintain a strong environment for investment in the newest wave - biopharmaceuticals, also known as biologics.

Importing Cheaper, Foreign-Produced Drugs Is Too Risky for American Consumers

Pat Choate | Posted 05.25.2011 | Politics
Pat Choate

Opening medicine distribution to massive imports from foreign-based producers will create enormous opportunities for unscrupulous sellers of unsafe medicines in America.